The Valley Desk

ArticleTargets (Basel)Published

Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer's Disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name University of Pennsylvania, Villanova University. Affiliation source

Publication record

Type
Article
Venue
Targets (Basel)
Published
Subject terms
Alzheimer’s disease; Docking; Drug Repurposing; Small Molecule Inhibitor; Brain Inflammation; Druggability Analysis; Drug-like Density; Single-nuclei Sequencing Analysis
PubMed ID
39897171
PubMed Central ID
PMC11786951
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal